This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
ProAxsis
Visit WebsiteProAxsis is a commercial medtech company, with a focus on respiratory diagnostics.
Products:
ProAxsis has developed a range of products incorporating their patented technology aiding the identification of Active proteases – validated biomarkers of disease activity.
- ProteaseTag ® Active Neutrophil Elastase Immunoassay
- NEATstik ®
- ProteaseTag ® Active Proteinase 3 Immunoassay
Clinical Services and R&D Projects:
ProAxsis offer a range of contract services from protease biomarker investigation, clinical trial and pharma services to academic support services
- All assays as a Service
- Clinical trial and/or development needs
- Assay development and customization
- Bespoke and tailored R&D Projects
Licensing agreements with organisations and pharmaceutical companies, including:
- Astra Zeneca (research use COVID serology testing)
- University of Geneva and University Hospital of Geneva (immunoassay “ELISA” for bone health & osteoporosis)
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital